Linicaltrial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linicaltrial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linicaltrial Today - Breaking & Trending Today

Curium Enrolls First Prostate Cancer Patients in its Phase

Patient enrollment in clinical trial. ....

United States , Luke Nordquist , Amy Bartalotta , Pierre Curie , Sakir Mutevelic , Chief Medical Officer , Vice President , Clinical Operations , Clinical Trial , Curium Us Llc ,

SciSparc Delivers Treatment for Autism Spectrum Disorder

The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment. ....

Oz Adler , Company Or Scisparc , Exchange Commission , Soroka Medical Center , Scisparc Ltd , Autism Spectrum Disorder , Chief Executive Officer , Aberrant Behavior Checklist Community , Clinical Global Impressions Improvement , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Nasdaq Sprc , Scisparc Ltd ,

Clearmind Medicine Receives Approval to Commence its Phase

For the first time, patients with alcohol use disorder will receive the company s unique and proprietary psychedelic - MEAI Vancouver, Canada, Feb. 23,. ....

Ramat Gan , Tel Aviv , British Columbia , United States , Adi Zuloff Shani , Mark Weiser , Canadian Securities Exchange , Medicine Inc , Johns Hopkins University School Of Medicine , Clearmind Medicine Inc , Frankfurt Stock Exchange , Psychiatric Division , Yale School Of Medicine Department Psychiatry , Ministry Of Health Israel , Sheba Medical Center , Yale School , Johns Hopkins University School , Nasdaq Cmnd , Learmind Medicine Inc ,

Investor Notice: Robbins LLP Informs Investors of Class

AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies. ....

Aaron Dumas Jr , Allovir Inc , Aaron Dumas , Case About , Allegedly Misled Investors Regarding Efficacy , Stock Watch , Robbins Llp , Allovir Inc , Lass Action ,

BioCardia Reports Third Quarter 2023 Business Highlights

SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the. ....

United States , Miranda Peto , Peter Altman , David Mcclung , York Heart Association Class , Exchange Commission , Device Agency , Company Annual Report On Form , Maryland Stem Cell Research Fund , Biocardia Inc , Company Phase , Exchange Commission On , Medicaid Services , Chronic Myocardial Ischemia , Autologous Cell Therapy , Ischemic Heart Failure , Therapy Trial , Heart Failure , Data Safety Monitoring Board , Minnesota Living , Heart Failure Questionnaire , Six Minute Walk , Therapy Heart Failure Trial , Therapy System , Medical Device Agency , Allogeneic Cell Therapy ,